Search Results 241-250 of 17167 for Albicans

  1. A Study of MPDL3280A (Anti-PD-L1 Antibody) Combined with Carboplatin and Paclitaxel , and with or without Bevacizumab, for Patients who have Stage IV Non-Squamous Non-Small Cell Lung Cancer - Mayo Clinic

    A Study of MPDL3280A (Anti-PD-L1 Antibody) Combined with Carboplatin and Paclitaxel , and with or without Bevacizumab, for Patients who have Stage IV Non- ...

  2. A Study of the Safety and Effectiveness of HBI-8000 with Nivolumab to Treat Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  3. Infectious Diseases - Clinical trials

    Learn about the expertise and services, including travel medicine, offered at Mayo Clinic to people with concerns about infectious diseases.

  4. A Study to Evaluate AVID200 in Myelofibrosis Patients - Mayo Clinic

    Increased levels of TGF-β1 were detected in serum, plasma and BM and positively correlated with both grade of BMF and extent of leukemic cell infiltration in ...

  5. Mayo Clinic

    ... . IMG-20451509. Home; cc-otc-cough-syrup_tablet. 3X your impact! Give Now! Your gift can go 3X as far to shape the future of cancer care.

  6. A Study to Evaluate LB1148 for Return of Gastrointestinal Function and Adhesions in Subjects Undergoing Bowel Resection - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  7. Ductal carcinoma in situ (DCIS) - Doctors and departments - Mayo Clinic

    Noninvasive breast cancer often has no symptoms. Find out about the causes, diagnosis and treatment of this form of breast cancer.

  8. Ahmad H. Al-Huniti, M.D. - Doctors and Medical Staff - Mayo Clinic

    Ahmad Al-Huniti, M.D., is a pediatric hematologist-oncologist with an interest in hemostasis and thrombosis. His clinical focus includes:.

  9. Efficacy, Safety, and Tolerability of Oral Full-Spectrum Microbiota® (CP101) in Subjects with Recurrence of Clostridium difficile Infection (PRISM3) - Mayo Clinic

    Efficacy, Safety, and Tolerability of Oral Full-Spectrum Microbiota® (CP101) in Subjects with Recurrence of Clostridium difficile Infection (PRISM3) · Overview.

  10. Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3) - Mayo Clinic

    This is a prospective, multicenter, randomized, double-blinded, placebo-controlled Phase 3 study of a microbiota suspension of intestinal microbes. Patients who ...